VALIDOGEN GmbH

Austria

Back to Profile

1-28 of 28 for VALIDOGEN GmbH Sort by
Query
Aggregations
IP Type
        Patent 16
        Trademark 12
Jurisdiction
        Canada 10
        United States 9
        World 6
        Europe 3
Date
2026 July 1
2026 (YTD) 1
2024 3
2023 1
2022 2
See more
IPC Class
C12N 15/81 - Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts 7
C07K 14/39 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from fungi from yeasts 6
C12N 15/67 - General methods for enhancing the expression 6
C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies 5
C12P 21/02 - Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione 5
See more
NICE Class
01 - Chemical and biological materials for industrial, scientific and agricultural use 12
42 - Scientific, technological and industrial services, research and design 12
40 - Treatment of materials; recycling, air and water treatment, 3
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services 3
Status
Pending 7
Registered / In Force 21

1.

Means and Methods for Increased Protein Expression by Use of a Combination of Transport Proteins and Either Chaperones or Transcription Factors

      
Application Number 19139578
Status Pending
Filing Date 2023-12-15
First Publication Date 2026-07-23
Owner
  • Boehringer Ingelheim RCV GmbH & Co KG (Austria)
  • Validogen GmbH (Austria)
  • Lonza Ltd. (Switzerland)
Inventor
  • Baumann, Kristin
  • Gasser, Brigitte
  • Mattanovich, Diethard
  • Prielhofer, Roland
  • Ata Akyol, Oezge

Abstract

The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of increasing the yield and/or titer of at least one protein of interest in a eukaryotic host cell, preferably a yeast, comprising overexpressing in said host cell a) at least one polynucleotide encoding at least one Sbh1 transport protein, and b) (i) at least one polynucleotide encoding at least one Kar2 endoplasmic reticulum helper protein; or (ii) at least one polynucleotide encoding at least one Hac transcription factor. The invention further relates to a recombinant eukaryotic host cell for manufacturing at least one protein of interest, which is engineered to overexpress at least one polynucleotide encoding said at least one Sbh1 transport protein, and b) (i) at least one polynucleotide encoding said at least one Kar2 endoplasmic reticulum helper protein; or (ii) at least one polynucleotide encoding said at least one Hac1 transcription factor as well as the use of said recombinant eukaryotic host cell for manufacturing at least one protein of interest.

IPC Classes  ?

  • C12N 15/81 - Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
  • C07K 14/39 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from fungi from yeasts
  • C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
  • C12N 9/18 - Carboxylic ester hydrolases

2.

MEANS AND METHODS FOR INCREASED PROTEIN EXPRESSION BY USE OF A COMBINATION OF TRANSPORT PROTEINS AND EITHER CHAPERONES OR TRANSCRIPTION FACTORS

      
Application Number EP2023086112
Publication Number 2024/126811
Status In Force
Filing Date 2023-12-15
Publication Date 2024-06-20
Owner
  • BOEHRINGER INGELHEIM RCV GMBH & CO KG (Austria)
  • VALIDOGEN GMBH (Austria)
  • LONZA LTD (Switzerland)
Inventor
  • Baumann, Kristin
  • Gasser, Brigitte
  • Mattanovich, Diethard
  • Prielhofer, Roland
  • Ata Akyol, Oezge

Abstract

The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of increasing the yield and/or titer of at least one protein of interest in a eukaryotic host cell, preferably a yeast, comprising overexpressing in said host cell a) at least one polynucleotide encoding at least one Sbh1 transport protein, and b) (i) at least one polynucleotide encoding at least one Kar2 endoplasmic reticulum helper protein; or (ii) at least one polynucleotide encoding at least one Hac1 transcription factor. The invention further relates to a recombinant eukaryotic host cell for manufacturing at least one protein of interest, which is engineered to overexpress at least one polynucleotide encoding said at least one Sbh1 transport protein, and b) (i) at least one polynucleotide encoding said at least one Kar2 endoplasmic reticulum helper protein; or (ii) at least one polynucleotide encoding said at least one Hac1 transcription factor as well as the use of said recombinant eukaryotic host cell for manufacturing at least one protein of interest.

IPC Classes  ?

  • C12N 15/67 - General methods for enhancing the expression

3.

MEANS AND METHODS FOR INCREASED PROTEIN EXPRESSION BY USE OF A COMBINATION OF TRANSPORT PROTEINS AND EITHER CHAPERONES OR TRANSCRIPTION FACTORS

      
Document Number 03274352
Status Pending
Filing Date 2023-12-15
Open to Public Date 2024-06-20
Owner
  • VALIDOGEN GMBH (Austria)
  • LONZA LTD (Switzerland)
  • BOEHRINGER INGELHEIM RCV GMBH & CO KG (Austria)
Inventor
  • Baumann, Kristin
  • Gasser, Brigitte
  • Mattanovich, Diethard
  • Prielhofer, Roland
  • Ata Akyol, Oezge

IPC Classes  ?

  • C12N 15/67 - General methods for enhancing the expression

4.

SIGNAL PEPTIDES FOR INCREASED PROTEIN SECRETION

      
Application Number 18276559
Status Pending
Filing Date 2022-02-11
First Publication Date 2024-05-02
Owner
  • BOEHRINGER INGELHEIM RCV GMBH & CO KG (Austria)
  • VALIDOGEN GMBH (Austria)
  • LONZA LTD (Switzerland)
Inventor
  • Zahrl, Richard
  • Ata Aykol, Oezge
  • Mattanovich, Diethard
  • Gasser, Brigitte

Abstract

The present invention relates to a nucleic acid molecule encoding a fusion protein comprising a secretion signal comprising (i) a signal peptide sequence originating from a KRE1 protein or a signal peptide sequence originating from a SWP1 protein; and optionally (ii) an α-mating factor (MFα) pro-sequence, and a protein of interest. The present invention further relates to a secretion signal as defined herein, an expression cassette comprising said nucleic acid molecule as well as recombinant eukaryotic host cells comprising said nucleic acid molecule or expression cassette. Further encompassed is a method of manufacturing a protein of interest in a eukaryotic host cell and a method of increasing the secretion of a protein of interest from a eukaryotic host cell. Further provided is the use of the secretion signal for increasing the secretion of a recombinant protein of interest from a eukaryotic host cell and the use of the recombinant host cell for manufacturing a recombinant protein of interest.

IPC Classes  ?

  • C12N 15/62 - DNA sequences coding for fusion proteins
  • C07K 14/39 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from fungi from yeasts
  • C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
  • C12N 9/10 - Transferases (2.)

5.

Recombinant host cell with altered membrane lipid composition

      
Application Number 17942774
Grant Number 12123044
Status In Force
Filing Date 2022-09-12
First Publication Date 2023-08-17
Grant Date 2024-10-22
Owner
  • BOEHRINGER INGELHEIM RCV GMBH & CO KG (Austria)
  • LONZA LTD. (Austria)
  • VALIDOGEN GMBH (Austria)
Inventor
  • Grillitsch, Karlheinz
  • Daum, Guenther
  • Grutsch, Andreas

Abstract

The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.

IPC Classes  ?

  • C12N 15/80 - Vectors or expression systems specially adapted for eukaryotic hosts for fungi
  • C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
  • C12N 15/67 - General methods for enhancing the expression
  • C12N 15/81 - Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
  • C12P 21/02 - Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

6.

SIGNAL PEPTIDES FOR INCREASED PROTEIN SECRETION

      
Document Number 03205520
Status Pending
Filing Date 2022-02-11
Open to Public Date 2022-08-18
Owner
  • BOEHRINGER INGELHEIM RCV GMBH & CO KG (Austria)
  • LONZA LTD. (Switzerland)
  • VALIDOGEN GMBH (Austria)
Inventor
  • Zahrl, Richard
  • Ata Akyol, Oezge
  • Mattanovich, Diethard
  • Gasser, Brigitte

Abstract

The present invention relates to a nucleic acid molecule encoding a fusion protein comprising a secretion signal comprising (i) a signal peptide sequence originating from a KRE1 protein or a signal peptide sequence originating from a SWP1 protein; and optionally (ii) an ?-mating factor (MF?) pro-sequence, and a protein of interest. The present invention further relates to a secretion signal as defined herein, an expression cassette comprising said nucleic acid molecule as well as recombinant eukaryotic host cells comprising said nucleic acid molecule or expression cassette. Further encompassed is a method of manufacturing a protein of interest in a eukaryotic host cell and a method of increasing the secretion of a protein of interest from a eukaryotic host cell. Further provided is the use of the secretion signal for increasing the secretion of a recombinant protein of interest from a eukaryotic host cell and the use of the recombinant host cell for manufacturing a recombinant protein of interest.

IPC Classes  ?

  • C07K 14/39 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from fungi from yeasts
  • C12N 9/24 - Hydrolases (3.) acting on glycosyl compounds (3.2)
  • C12N 15/62 - DNA sequences coding for fusion proteins

7.

SIGNAL PEPTIDES FOR INCREASED PROTEIN SECRETION

      
Application Number EP2022053425
Publication Number 2022/171827
Status In Force
Filing Date 2022-02-11
Publication Date 2022-08-18
Owner
  • BOEHRINGER INGELHEIM RCV GMBH & CO KG (Austria)
  • VALIDOGEN GMBH (Austria)
  • LONZA LTD (Switzerland)
Inventor
  • Zahrl, Richard
  • Ata Aykol, Oezge
  • Mattanovich, Diethard
  • Gasser, Brigitte

Abstract

The present invention relates to a nucleic acid molecule encoding a fusion protein comprising a secretion signal comprising (i) a signal peptide sequence originating from a KRE1 protein or a signal peptide sequence originating from a SWP1 protein; and optionally (ii) an α-mating factor (MFα) pro-sequence, and a protein of interest. The present invention further relates to a secretion signal as defined herein, an expression cassette comprising said nucleic acid molecule as well as recombinant eukaryotic host cells comprising said nucleic acid molecule or expression cassette. Further encompassed is a method of manufacturing a protein of interest in a eukaryotic host cell and a method of increasing the secretion of a protein of interest from a eukaryotic host cell. Further provided is the use of the secretion signal for increasing the secretion of a recombinant protein of interest from a eukaryotic host cell and the use of the recombinant host cell for manufacturing a recombinant protein of interest.

IPC Classes  ?

  • C12N 15/62 - DNA sequences coding for fusion proteins
  • C07K 14/39 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from fungi from yeasts
  • C12N 9/24 - Hydrolases (3.) acting on glycosyl compounds (3.2)

8.

Recombinant host cell with altered membrane lipid composition

      
Application Number 16499072
Grant Number 11479798
Status In Force
Filing Date 2018-03-28
First Publication Date 2021-09-30
Grant Date 2022-10-25
Owner
  • BOEHRINGER INGELHEIM RCV GMBH & CO KG (Austria)
  • VALIDOGEN GMBH (Austria)
  • BIOMIN HOLDING GMBH (Austria)
  • LONZA LTD. (Switzerland)
Inventor
  • Grillitsch, Karlheinz
  • Daum, Guenther
  • Grutsch, Andreas

Abstract

The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.

IPC Classes  ?

  • C12N 9/10 - Transferases (2.)
  • C12N 15/81 - Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
  • C12P 21/02 - Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
  • C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
  • C12N 15/67 - General methods for enhancing the expression

9.

MEANS AND METHODS FOR INCREASED PROTEIN EXPRESSION BY USE OF TRANSCRIPTION FACTORS

      
Application Number 17254238
Status Pending
Filing Date 2019-06-27
First Publication Date 2021-09-02
Owner
  • Boehringer Ingelheim RCV GmbH & CO KG (Austria)
  • Validogen GmbH (Austria)
  • Lonza Ltd (Switzerland)
Inventor
  • Zahrl, Richard
  • Burgard, Jonas
  • Baumann, Kristin
  • Mattanovich, Diethard
  • Gasser, Brigitte

Abstract

The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of increasing the yield of a protein of interest (POI) in a eukaryotic host cell, preferably a yeast, by overexpressing at least one polynucleotide encoding at least one transcription factor of the present invention, preferably Msn4/2. The invention relates further to a recombinant eukaryotic host cell for manufacturing a POI, wherein the host cell is engineered to overexpress at least one polynucleotide encoding at least one transcription factor as well as the use of the host cell for manufacturing a POI.

IPC Classes  ?

  • C12N 15/81 - Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
  • C07K 16/00 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies

10.

MEANS AND METHODS FOR INCREASED PROTEIN EXPRESSION BY USE OF TRANSCRIPTION FACTORS

      
Application Number EP2019067133
Publication Number 2020/002494
Status In Force
Filing Date 2019-06-27
Publication Date 2020-01-02
Owner
  • BOEHRINGER INGELHEIM RCV GMBH & CO KG (Austria)
  • VALIDOGEN GMBH (Austria)
  • BIOMIN HOLDING GMBH (Austria)
  • LONZA LTD (Switzerland)
Inventor
  • Zahrl, Richard
  • Burgard, Jonas
  • Baumann, Kristin
  • Mattanovich, Diethard
  • Gasser, Brigitte

Abstract

The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of increasing the yield of a protein of interest (POI) in a eukaryotic host cell, preferably a yeast, by overexpressing at least one polynucleotide encoding at least one transcription factor of the present invention, preferably Msn4/2. The invention relates further to a recombinant eukaryotic host cell for manufacturing a POI, wherein the host cell is engineered to overexpress at least one polynucleotide encoding at least one transcription factor as well as the use of the host cell for manufacturing a POI.

IPC Classes  ?

11.

MEANS AND METHODS FOR INCREASED PROTEIN EXPRESSION BY USE OF TRANSCRIPTION FACTORS

      
Document Number 03103988
Status Pending
Filing Date 2019-06-27
Open to Public Date 2020-01-02
Owner
  • BOEHRINGER INGELHEIM RCV GMBH & CO KG (Austria)
  • VALIDOGEN GMBH (Austria)
  • LONZA LTD (Switzerland)
Inventor
  • Zahrl, Richard
  • Burgard, Jonas
  • Baumann, Kristin
  • Mattanovich, Diethard
  • Gasser, Brigitte

Abstract

The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of increasing the yield of a protein of interest (POI) in a eukaryotic host cell, preferably a yeast, by overexpressing at least one polynucleotide encoding at least one transcription factor of the present invention, preferably Msn4/2. The invention relates further to a recombinant eukaryotic host cell for manufacturing a POI, wherein the host cell is engineered to overexpress at least one polynucleotide encoding at least one transcription factor as well as the use of the host cell for manufacturing a POI.

IPC Classes  ?

12.

VALIDOGEN

      
Application Number 1495132
Status Registered
Filing Date 2019-04-02
Registration Date 2019-04-02
Owner VALIDOGEN GmbH (Austria)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Chemical, biological, biochemical and biotechnological preparations; biochemicals, in particular microorganisms, in particular yeast and bacteria for use in protein expression; microbial production strains for producing proteins, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; microbial production strains for producing plasmid DNA; yeast strains, other than for making wine, medical or veterinary use; bacterial strains, other than for making wine, medical or veterinary use; proteins for use in science; proteins, not for scientific purposes and medical or veterinary use; proteins for use in industry, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; proteins, in particular enzymes, for use in production processes, in particular for producing foodstuffs, animal feed, chemicals, diagnostics, cosmetics, pharmaceuticals and biopharmaceuticals; proteins for use in industry, in particular for industrial, analytic and diagnostic purposes and cleaning purposes; enzymes derived from biotechnological processes for use in industry; nucleic recombinant acids, in particular plasmid DNA; nucleic acids, in particular deoxyribonucleic acids, in particular for protein production. Consultancy in relation to biochemistry/biotechnology; research and development in the field of chemistry/biochemistry/biotechnology; services of a chemical and/or biological laboratory; conducting of biological and biotechnological tests; biotechnological research relating to industry; biotechnological research relating to enzymatic synthesis; information on the subject of scientific research in the field of biochemistry and biotechnology; working on and evaluation of chemical syntheses; working on and evaluation of chemical analyses; research and development in the field of biochemistry and biotechnology, in particular in relation to protein expression and protein production and plasmid DNA production; research and development services relating to science; development of proteins; scientific research and development services, namely, production of proteins, plasmid DNA production, plasmid DNA purification, modification of proteins, purification of proteins, DNA manipulation and cell banking services; development of bioprocesses; strain development, in particular development of production strains for producing plasmid DNA; enzyme engineering; development of protein production processes; development of processes for producing plasmid DNA; plasmid DNA synthesis; development of methods for the purification of plasmid DNA; development of protein purification methods.

13.

UNLOCK PICHIA

      
Application Number 1484728
Status Registered
Filing Date 2019-04-02
Registration Date 2019-04-02
Owner VALIDOGEN GmbH (Austria)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Chemical, biological, biochemical and biotechnological preparations; biochemicals, in particular microorganisms, in particular yeast and bacteria for use in protein expression; microbial production strains for producing proteins, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; microbial production strains for producing plasmid DNA; yeast strains, other than for making wine, medical or veterinary use; bacterial strains, other than for making wine, medical or veterinary use; proteins for use in science; proteins, not for scientific purposes and medical or veterinary use; proteins for use in industry, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; proteins, in particular enzymes, for use in production processes, in particular for producing foodstuffs, animal feed, chemicals, diagnostics, cosmetics, pharmaceuticals and biopharmaceuticals; proteins for use in industry, in particular for industrial, analytic and diagnostic purposes and cleaning purposes; enzymes derived from biotechnological processes for use in industry; nucleic recombinant acids, in particular plasmid DNA; nucleic acids, in particular deoxyribonucleic acids, in particular for protein production. Consultancy in relation to biochemistry/biotechnology; research and development in the field of chemistry/biochemistry/biotechnology; services of a chemical and/or biological laboratory; conducting of biological and biotechnological tests; biotechnological research relating to industry; biotechnological research relating to enzymatic synthesis; information on the subject of scientific research in the field of biochemistry and biotechnology; working on and evaluation of chemical syntheses; working on and evaluation of chemical analyses; research and development in the field of biochemistry and biotechnology, in particular in relation to protein expression and protein production and plasmid DNA production; research and development services relating to science; development of proteins; scientific research and development services, namely, production of proteins, plasmid DNA production, plasmid DNA purification, modification of proteins, purification of proteins, DNA manipulation and cell banking services; development of bioprocesses; strain development, in particular development of production strains for producing proteins; strain development, in particular development of production strains for producing plasmid DNA; enzyme engineering; development of protein production processes; development of processes for producing plasmid DNA; plasmid DNA synthesis; development of methods for the purification of plasmid DNA; development of protein purification methods.

14.

VALIDOGEN

      
Application Number 1485203
Status Registered
Filing Date 2019-04-02
Registration Date 2019-04-02
Owner VALIDOGEN GmbH (Austria)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Chemical, biological, biochemical and biotechnological preparations; biochemicals, in particular microorganisms, in particular yeast and bacteria for use in protein expression; microbial production strains for producing proteins, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; microbial production strains for producing plasmid DNA; yeast strains, other than for making wine, medical or veterinary use; bacterial strains, other than for making wine, medical or veterinary use; proteins for use in science; proteins, not for scientific purposes and medical or veterinary use; proteins for use in industry, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; proteins, in particular enzymes, for use in production processes, in particular for producing foodstuffs, animal feed, chemicals, diagnostics, cosmetics, pharmaceuticals and biopharmaceuticals; proteins for use in industry, in particular for industrial, analytic and diagnostic purposes and cleaning purposes; enzymes derived from biotechnological processes for use in industry; nucleic recombinant acids, in particular plasmid DNA; nucleic acids, in particular deoxyribonucleic acids, in particular for protein production. Consultancy in relation to biochemistry/biotechnology; research and development in the field of chemistry/biochemistry/biotechnology; services of a chemical and/or biological laboratory; conducting of biological and biotechnological tests; biotechnological research relating to industry; biotechnological research relating to enzymatic synthesis; information on the subject of scientific research in the field of biochemistry and biotechnology; working on and evaluation of chemical syntheses; working on and evaluation of chemical analyses; research and development in the field of biochemistry and biotechnology, in particular in relation to protein expression and protein production and plasmid DNA production; research and development services relating to science; development of proteins; scientific research and development services, namely, production of proteins, plasmid DNA production, plasmid DNA purification, modification of proteins, purification of proteins, DNA manipulation and cell banking services; development of bioprocesses; strain development, in particular development of production strains for producing proteins; strain development, in particular development of production strains for producing plasmid DNA; enzyme engineering; development of protein production processes; development of processes for producing plasmid DNA; plasmid DNA synthesis; development of methods for the purification of plasmid DNA; development of protein purification methods.

15.

UNLOCK PICHIA

      
Serial Number 79266196
Status Registered
Filing Date 2019-04-02
Registration Date 2020-07-28
Owner VALIDOGEN GmbH (Austria)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Chemical, biological, biochemical and biotechnological preparations for scientific and commercial purposes; Biochemicals, namely, microorganisms in the form of the yeast Komagataella phaffii known as Pichia pastoris for use in protein expression; Microbial production strains, namely, Komagataella phaffii known as Pichia pastoris for producing proteins, in particular for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries and the laundry and cleaning preparations industries; Yeast strains, other than for making wine, medical or veterinary use; Proteins for use in science; Proteins, not for scientific purposes and medical or veterinary use; Proteins for use in industries, in particular for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries and the laundry and cleaning preparations industries; Proteins, specifically enzymes, for use in production processes, in particular for producing foodstuffs, animal feed, chemicals, diagnostics, cosmetics, pharmaceuticals and biopharmaceuticals; Proteins for industrial use, in particular for industrial, analytic and diagnostic purposes and cleaning purposes; Enzymes derived from biotechnological processes for industrial use; all the aforementioned primarily consisting of Komagataella phaffii known as Pichia pastoris yeast Consultancy, namely, providing information on the subject of scientific research in the field of biochemistry and biotechnology; Research and development in the field of chemistry, biochemistry, and biotechnology; Chemical and biological laboratory services; Conducting of biological and biotechnological tests for research and commercial purposes; Industrial biotechnological research; Biotechnological research in the field of enzymatic synthesis; Working on and evaluation of chemical syntheses; Working on and evaluation of chemical analyses; Research and development in the field of biochemistry and biotechnology, in particular in relation to protein expression and protein production; Research and development services relating to biotechnical biochemistry science; Development of proteins for use in pharmaceuticals, biotechnology, and medical and veterinary diagnostics; Development of bioprocesses for protein production; Strain development services, namely development of production strains for producing proteins; Enzyme engineering for others; Development of protein production processes for others; Development of protein purification methods; all the aforementioned in the field of Komagataella phaffii known as Pichia pastoris yeast

16.

VALIDOGEN

      
Serial Number 79266384
Status Registered
Filing Date 2019-04-02
Registration Date 2020-07-21
Owner VALIDOGEN GmbH (Austria)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Chemical, biological, biochemical and biotechnological preparations, namely, for scientific and commercial purposes; biochemicals, namely, microorganisms in the form of, yeast and bacteria for use in protein expression; microbial production strains, namely, Komagataella phaffii strains known as Pichia pastoris and Escherichia coli strains for producing proteins, in particular for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries, and the laundry and cleaning preparations industries; microbial production strains for producing plasmid DNA; yeast strains, other than for making wine, medical or veterinary use; bacterial strains, other than for making wine, medical or veterinary use; proteins for use in science; proteins, not for scientific purposes and medical or veterinary use; proteins for use in industry, in particular for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries, and the laundry and cleaning preparations industries; proteins specifically, enzymes, for use in production processes, namely, for producing foodstuffs, animal feed, chemicals, diagnostics, cosmetics, pharmaceuticals and biopharmaceuticals; proteins for industrial use in particular for industrial, analytic and diagnostic purposes and cleaning purposes; enzymes derived from biotechnological processes for industrial use; nucleic recombinant acids, in particular plasmid DNA, for laboratory use; nucleic acids, in particular deoxyribonucleic acids, in particular for protein production Consultancy, namely, providing information on the subject of scientific research in the field of biochemistry and biotechnology; research and development in the field of chemistry, biochemistry, and biotechnology; chemical and biological laboratory services; conducting of biological and biotechnological tests for commercial and scientific purposes; industrial biotechnological research; biotechnological research in the field of enzymatic synthesis; providing information on the subject of scientific research in the field of biochemistry and biotechnology; working on and evaluation of chemical syntheses; working on and evaluation of chemical analyses; research and development in the field of biochemistry and biotechnology, in particular in relation to protein expression and protein production and plasmid DNA production; research and development services relating to biotechnical biochemistry science; development of proteins for use in pharmaceuticals, biotechnology, and medical and veterinary diagnostics; scientific research and development services, namely, production of proteins, plasmid DNA production, plasmid DNA purification, modification of proteins, purification of proteins, DNA manipulation and cell banking services for others; development of bioprocesses for protein production and plasmid DNA production; strain development services, namely, development of production strains for producing proteins; strain development, in particular the development of production strains for producing plasmid DNA; enzyme engineering for others; development of protein production processes for others; development of processes for producing plasmid DNA for others; plasmid DNA synthesis for others; development of plasmid DNA purification methods; development of protein purification methods

17.

VALIDOGEN

      
Serial Number 79270687
Status Registered
Filing Date 2019-04-02
Registration Date 2020-09-22
Owner VALIDOGEN GmbH (Austria)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Chemical, biological, biochemical and biotechnological preparations, namely, for scientific and commercial purposes; biochemicals, namely, microorganisms in the form of, yeast and bacteria for use in protein expression; microbial production strains, namely, Komagataella phaffii strains known as Pichia pastoris and Escherichia coli strains for producing proteins, in particular for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries, and the laundry and cleaning preparations industries; microbial production strains for producing plasmid DNA; yeast strains, other than for making wine, medical or veterinary use; bacterial strains, other than for making wine, medical or veterinary use; proteins for use in science; proteins, not for scientific purposes and medical or veterinary use; proteins for use in industry, in particular for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries, and the laundry and cleaning preparations industries; proteins specifically, enzymes, for use in production processes, namely, for producing foodstuffs, animal feed, chemicals, diagnostics, cosmetics, pharmaceuticals and biopharmaceuticals; proteins for industrial use in particular for industrial, analytic and diagnostic purposes and cleaning purposes; enzymes derived from biotechnological processes for industrial use; nucleic recombinant acids, in particular plasmid DNA, for laboratory use; nucleic acids, in particular deoxyribonucleic acids, in particular for protein production Consultancy, namely, providing information on the subject of scientific research in the field of biochemistry and biotechnology; research and development in the field of chemistry, biochemistry, and biotechnology; chemical and biological laboratory services; conducting of biological and biotechnological tests for commercial and scientific purposes; industrial biotechnological research; biotechnological research in the field of enzymatic synthesis; providing information on the subject of scientific research in the field of biochemistry and biotechnology; working on and evaluation of chemical syntheses; working on and evaluation of chemical analyses; research and development in the field of biochemistry and biotechnology, in particular in relation to protein expression and protein production and plasmid DNA production; research and development services relating to biotechnical biochemistry science; development of proteins for use in pharmaceuticals, biotechnology, and medical and veterinary diagnostics; scientific research and development services, namely, production of proteins, plasmid DNA production, plasmid DNA purification, modification of proteins, purification of proteins, DNA manipulation and cell banking services for others; development of bioprocesses for protein production and plasmid DNA production; strain development services, namely, development of production strains for producing proteins; strain development, in particular the development of production strains for producing plasmid DNA; enzyme engineering for others; development of protein production processes for others; development of processes for producing plasmid DNA for others; plasmid DNA synthesis for others; development of plasmid DNA purification methods; development of protein purification methods

18.

VALIDOGEN

      
Application Number 195232000
Status Registered
Filing Date 2019-03-19
Registration Date 2024-02-08
Owner VALIDOGEN GmbH (Austria)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Chemical, biological, biochemical and biotechnological preparations for scientific and commercial purposes; Biochemicals, in particular microorganisms, in particular yeast and bacteria for use in protein expression; Microbial production strains, namely, yeast and bacteria for producing proteins, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; Microbial production strains for producing plasmid DNA; Yeast for scientific and commercial purposes; Bacterial strains; Proteins for use in biotechnical biochemistry science; Proteins, not for scientific purposes for scientific and commercial purposes; Proteins for use in industry, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; Proteins, in particular enzymes, for use in production processes, in particular for producing foodstuffs, animal feed, chemicals, diagnostics, cosmetics, pharmaceuticals and biopharmaceuticals; Proteins for use in industry, for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries and the laundry and cleaning preparations industries; Enzymes derived from biotechnological processes for use in industry; Nucleic recombinant acids, In particular plasmid DNA; Nucleic acids, In particular deoxyribonucleic acids, in particular for protein production (1) Consultancy in relation to biochemistry/biotechnology; Research and development in the field of chemistry/biochemistry/biotechnology; Services of a chemical and biological laboratory; Conducting of biological and biotechnological tests; Biotechnological research relating to industry; Biotechnological research relating to enzymatic synthesis; Information on the subject of scientific research in the field of biochemistry and biotechnology; Processing and evaluation of chemical syntheses; Processing and evaluation of chemical analyses; Research and development in the field of biochemistry and biotechnology, in particular in relation to protein expression and protein production and plasmid DNA production; Research and development services relating to biotechnical biochemistry science; DNA manipulation for scientific research and commercial purposes; Development of proteins for use in pharmaceutical and biotechnological preparations, food preparations, animal feed preparations, chemical preparations, agricultural preparations, diagnostic preparations, cosmetic preparations, laundry preparations and medical and veterinary diagnostics; Production of proteins for use in pharmaceutical and biotechnological preparations, food preparations, animal feed preparations, chemical preparations, agricultural preparations, diagnostic preparations, cosmetic preparations, laundry preparations and medical and veterinary diagnostics; Plasmid DNA production; Modification of proteins for use in pharmaceutical and biotechnological preparations, food preparations, animal feed preparations, chemical preparations, agricultural preparations, diagnostic preparations, cosmetic preparations, laundry preparations and medical and veterinary diagnostics; Development of bioprocesses for protein production and plasmid DNA production; Strain development, in particular development of production strains for producing proteins for use in pharmaceutical and biotechnological preparations, food preparations, animal feed preparations, chemical preparations, agricultural preparations, diagnostic preparations, cosmetic preparations, laundry preparations and medical and veterinary diagnostics; Strain development, in particular development of production strains for producing plasmid DNA; Purification of proteins for use in pharmaceutical and biotechnological preparations, food preparations, animal feed preparations, chemical preparations, agricultural preparations, diagnostic preparations, cosmetic preparations, laundry preparations and medical and veterinary diagnostics; Plasmid DNA purification; Services in relation to cell banking systems; Enzyme engineering; Development of protein production processes for use in pharmaceutical and biotechnological preparations, food preparations, animal feed preparations, chemical preparations, agricultural preparations, diagnostic preparations, cosmetic preparations, laundry preparations and medical and veterinary diagnostics; Development of processes for producing plasmid DNA; Plasmid DNA synthesis; Development of methods for the purification of plasmid DNA; Development of protein purification methods in particular for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries and the laundry and cleaning preparations industries

19.

UNLOCK PICHIA

      
Application Number 195231600
Status Registered
Filing Date 2019-03-19
Registration Date 2024-02-08
Owner VALIDOGEN GmbH (Austria)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Chemical, biological, biochemical and biotechnological preparations for scientific and commercial purposes; Biochemicals, in particular microorganisms, in particular yeast and bacteria for use in protein expression; Microbial production strains, namely, Komagataella phaffii known as Pichia pastoris for producing proteins, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; Yeast for scientific and commercial purposes; Proteins for use in biotechnical biochemistry science; Proteins, not for scientific purposes and other than for medical or veterinary use; Proteins for use in industry, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; Proteins, in particular enzymes, for use in production processes, in particular for producing foodstuffs, animal feed, chemicals, diagnostics, cosmetics, pharmaceuticals and biopharmaceuticals; Proteins for use in industries, in particular for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries and the laundry and cleaning preparations industries; Enzymes derived from biotechnological processes for use in industry; Nucleic acids, in particular deoxyribonucleic acids, in particular for protein production (1) Consultancy in relation to biochemistry/biotechnology; Research and development in the field of chemistry/biochemistry/biotechnology; Services of a chemical and biological laboratory; Conducting of biological and biotechnological tests; Biotechnological research relating to industry; Biotechnological research relating to enzymatic synthesis; Information on the subject of scientific research in the field of biochemistry and biotechnology; Processing and evaluation of chemical syntheses; Processing and evaluation of chemical analyses; Research and development in the field of biochemistry and biotechnology, in particular in relation to protein expression and protein production; Research and development services relating to biotechnical biochemistry science; DNA manipulation for scientific research and commerical purposes; Development of proteins for use in pharmaceutical and biotechnological preparations, food preparations, animal feed preparations, chemical preparations, agricultural preparations, diagnostic preparations, cosmetic preparations, laundry preparations and medical and veterinary diagnostics; Production of proteins for use in pharmaceutical and biotechnological preparations, food preparations, animal feed preparations, chemical preparations, agricultural preparations, diagnostic preparations, cosmetic preparations, laundry preparations and medical and veterinary diagnostics; Modification of proteins for use in pharmaceutical and biotechnological preparations, food preparations, animal feed preparations, chemical preparations, agricultural preparations, diagnostic preparations, cosmetic preparations, laundry preparations and medical and veterinary diagnostics; Development of bioprocesses for protein production; Strain development, in particular development of production strains for producing proteins for use in pharmaceutical and biotechnological preparations, food preparations, animal feed preparations, chemical preparations, agricultural preparations, diagnostic preparations, cosmetic preparations, laundry preparations and medical and veterinary diagnostics; Purification of proteins for use in pharmaceutical and biotechnological preparations, food preparations, animal feed preparations, chemical preparations, agricultural preparations, diagnostic preparations, cosmetic preparations, laundry preparations and medical and veterinary diagnostics; Services in relation to cell banking systems; Enzyme engineering; Development of protein production processes in particular for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries and the laundry and cleaning preparations industries; Development of protein purification methods in particular for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries and the laundry and cleaning preparations industries

20.

VALIDOGEN

      
Application Number 195231700
Status Registered
Filing Date 2019-03-19
Registration Date 2024-02-08
Owner VALIDOGEN GmbH (Austria)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 40 - Treatment of materials; recycling, air and water treatment,
  • 42 - Scientific, technological and industrial services, research and design
  • 44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services

Goods & Services

(1) Chemical, biological, biochemical and biotechnological preparations for scientific and commercial purposes; Biochemicals, in particular microorganisms, in particular yeast and bacteria for use in protein expression; Microbial production strains, namely, yeast and bacteria for producing proteins, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; Microbial production strains for producing plasmid DNA; Yeast for scientific and commercial purposes; Bacterial strains; Proteins for use in biotechnical biochemistry science; Proteins, not for scientific purposes for scientific and commercial purposes; Proteins for use in industry, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; Proteins, in particular enzymes, for use in production processes, in particular for producing foodstuffs, animal feed, chemicals, diagnostics, cosmetics, pharmaceuticals and biopharmaceuticals; Proteins for use in industry, for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries and the laundry and cleaning preparations industries; Enzymes derived from biotechnological processes for use in industry; Nucleic recombinant acids, In particular plasmid DNA; Nucleic acids, In particular deoxyribonucleic acids, in particular for protein production (1) Consultancy in relation to biochemistry/biotechnology; Research and development in the field of chemistry/biochemistry/biotechnology; Services of a chemical and biological laboratory; Conducting of biological and biotechnological tests; Biotechnological research relating to industry; Biotechnological research relating to enzymatic synthesis; Information on the subject of scientific research in the field of biochemistry and biotechnology; Processing and evaluation of chemical syntheses; Processing and evaluation of chemical analyses; Research and development in the field of biochemistry and biotechnology, in particular in relation to protein expression and protein production and plasmid DNA production; Research and development services relating to biotechnical biochemistry science; DNA manipulation for scientific research and commercial purposes; Development of proteins for use in pharmaceutical and biotechnological preparations, food preparations, animal feed preparations, chemical preparations, agricultural preparations, diagnostic preparations, cosmetic preparations, laundry preparations and medical and veterinary diagnostics; Production of proteins for use in pharmaceutical and biotechnological preparations, food preparations, animal feed preparations, chemical preparations, agricultural preparations, diagnostic preparations, cosmetic preparations, laundry preparations and medical and veterinary diagnostics; Plasmid DNA production; Modification of proteins for use in pharmaceutical and biotechnological preparations, food preparations, animal feed preparations, chemical preparations, agricultural preparations, diagnostic preparations, cosmetic preparations, laundry preparations and medical and veterinary diagnostics; Development of bioprocesses for protein production and plasmid DNA production; Strain development, in particular development of production strains for producing proteins for use in pharmaceutical and biotechnological preparations, food preparations, animal feed preparations, chemical preparations, agricultural preparations, diagnostic preparations, cosmetic preparations, laundry preparations and medical and veterinary diagnostics; Strain development, in particular development of production strains for producing plasmid DNA; Purification of proteins for use in pharmaceutical and biotechnological preparations, food preparations, animal feed preparations, chemical preparations, agricultural preparations, diagnostic preparations, cosmetic preparations, laundry preparations and medical and veterinary diagnostics; Plasmid DNA purification; Services in relation to cell banking systems; Enzyme engineering; Development of protein production processes in particular for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries and the laundry and cleaning preparations industries; Development of processes for producing plasmid DNA; Plasmid DNA synthesis; Development of methods for the purification of plasmid DNA; Development of protein purification methods in particular for the pharmaceutical and biopharmaceutical industries, food industries, animal feed industries, chemical industries, agricultural industries, diagnostics industries, cosmetics industries and the laundry and cleaning preparations industries

21.

UNLOCK PICHIA

      
Application Number 017970066
Status Registered
Filing Date 2018-10-17
Registration Date 2019-03-04
Owner VALIDOGEN GmbH (Austria)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Chemical, biological, biochemical and biotechnological preparations; Biochemicals, In particular microorganisms, in particular yeast and bacteria for use in protein expression; Microbial production strains for producing proteins, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; Yeast strains; Proteins for use in science; Proteins, not for scientific purposes; Proteins for use in industry, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; Proteins, in particular enzymes, for use in production processes, in particular for producing foodstuffs, animal feed, chemicals, diagnostics, cosmetics, pharmaceuticals and biopharmaceuticals; Proteins for use in industry, in particular for industrial, analytic and diagnostic purposes and cleaning purposes; Enzymes derived from biotechnological processes for use in industry; Nucleic acids, in particular deoxyribonucleic acids, in particular for protein production. Consultancy in relation to biochemistry/biotechnology; Research and development in the field of chemistry/biochemistry/biotechnology; Services of a chemical and/or biological laboratory; Conducting of biological and biotechnological tests; Biotechnological research relating to industry; Biotechnological research relating to enzymatic synthesis; Information on the subject of scientific research in the field of biochemistry and biotechnology; Working on and evaluation of chemical syntheses; Working on and evaluation of chemical analyses; Research and development in the field of biochemistry and biotechnology, in particular in relation to protein expression and protein production; Research and development services relating to science; DNA manipulation; Development of proteins; Production of proteins; Modification of proteins; Development of bioprocesses; Strain development, in particular development of production strains for producing proteins; Purification of proteins; Services in relation to cell banking systems; Enzyme engineering; Development of protein production processes; Development of protein purification methods.

22.

VALIDOGEN

      
Application Number 017970069
Status Registered
Filing Date 2018-10-17
Registration Date 2019-03-06
Owner VALIDOGEN GmbH (Austria)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Chemical, biological, biochemical and biotechnological preparations; Biochemicals, In particular microorganisms, in particular yeast and bacteria for use in protein expression; Microbial production strains for producing proteins, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; Microbial production strains for producing plasmid DNA; Yeast strains; Bacterial strains; Proteins for use in science; Proteins, not for scientific purposes; Proteins for use in industry, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; Proteins, in particular enzymes, for use in production processes, in particular for producing foodstuffs, animal feed, chemicals, diagnostics, cosmetics, pharmaceuticals and biopharmaceuticals; Proteins for use in industry, in particular for industrial, analytic and diagnostic purposes and cleaning purposes; Enzymes derived from biotechnological processes for use in industry; Nucleic recombinant acids, In particular plasmid DNA; Nucleic acids, in particular deoxyribonucleic acids, in particular for protein production. Consultancy in relation to biochemistry/biotechnology; Research and development in the field of chemistry/biochemistry/biotechnology; Services of a chemical and/or biological laboratory; Conducting of biological and biotechnological tests; Biotechnological research relating to industry; Biotechnological research relating to enzymatic synthesis; Information on the subject of scientific research in the field of biochemistry and biotechnology; Working on and evaluation of chemical syntheses; Working on and evaluation of chemical analyses; Research and development in the field of biochemistry and biotechnology, in particular in relation to protein expression and protein production and plasmid DNA production; Research and development services relating to science; DNA manipulation; Development of proteins; Production of proteins; Plasmid DNA production; Modification of proteins; Development of bioprocesses; Strain development, in particular development of production strains for producing proteins; Strain development, in particular development of production strains for producing plasmid DNA; Purification of proteins; Plasmid DNA purification; Services in relation to cell banking systems; Enzyme engineering; Development of protein production processes; Development of processes for producing plasmid DNA; Plasmid DNA synthesis; Development of methods for the purification of plasmid DNA; Development of protein purification methods.

23.

VALIDOGEN

      
Application Number 017970320
Status Registered
Filing Date 2018-10-17
Registration Date 2019-03-06
Owner VALIDOGEN GmbH (Austria)
NICE Classes  ?
  • 01 - Chemical and biological materials for industrial, scientific and agricultural use
  • 42 - Scientific, technological and industrial services, research and design

Goods & Services

Chemical, biological, biochemical and biotechnological preparations; Biochemicals, In particular microorganisms, in particular yeast and bacteria for use in protein expression; Microbial production strains for producing proteins, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; Microbial production strains for producing plasmid DNA; Yeast strains; Bacterial strains; Proteins for use in science; Proteins, not for scientific purposes; Proteins for use in industry, in particular for the pharmaceutical and biopharmaceutical industry, food industry, animal feed industry, chemical industry, agricultural industry, diagnostics industry, cosmetics industry and the laundry and cleaning preparations industry; Proteins, in particular enzymes, for use in production processes, in particular for producing foodstuffs, animal feed, chemicals, diagnostics, cosmetics, pharmaceuticals and biopharmaceuticals; Proteins for use in industry, in particular for industrial, analytic and diagnostic purposes and cleaning purposes; Enzymes derived from biotechnological processes for use in industry; Nucleic recombinant acids, In particular plasmid DNA; Nucleic acids, In particular deoxyribonucleic acids, in particular for protein production. Consultancy in relation to biochemistry/biotechnology; Research and development in the field of chemistry/biochemistry/biotechnology; Services of a chemical and/or biological laboratory; Conducting of biological and biotechnological tests; Biotechnological research relating to industry; Biotechnological research relating to enzymatic synthesis; Information on the subject of scientific research in the field of biochemistry and biotechnology; Working on and evaluation of chemical syntheses; Working on and evaluation of chemical analyses; Research and development in the field of biochemistry and biotechnology, in particular in relation to protein expression and protein production and plasmid DNA production; Research and development services relating to science; DNA manipulation; Development of proteins; Production of proteins; Plasmid DNA production; Modification of proteins; Development of bioprocesses; Strain development, in particular development of production strains for producing proteins; Strain development, in particular development of production strains for producing plasmid DNA; Purification of proteins; Plasmid DNA purification; Services in relation to cell banking systems; Enzyme engineering; Development of protein production processes; Development of processes for producing plasmid DNA; Plasmid DNA synthesis; Development of methods for the purification of plasmid DNA; Development of protein purification methods.

24.

RECOMBINANT HOST CELL WITH ALTERED MEMBRANE LIPID COMPOSITION

      
Document Number 03056920
Status Pending
Filing Date 2018-03-28
Open to Public Date 2018-10-04
Owner
  • VALIDOGEN GMBH (Austria)
  • LONZA LTD (Switzerland)
  • BOEHRINGER INGELHEIM RCV GMBH & CO KG (Austria)
Inventor
  • Grillitsch, Karlheinz
  • Daum, Guenther
  • Grutsch, Andreas

Abstract

The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.

IPC Classes  ?

  • C12N 15/63 - Introduction of foreign genetic material using vectorsVectorsUse of hosts thereforRegulation of expression
  • C12P 21/00 - Preparation of peptides or proteins

25.

Recombinant host cell for expressing proteins of interest

      
Application Number 15304504
Grant Number 10590427
Status In Force
Filing Date 2015-04-16
First Publication Date 2017-02-16
Grant Date 2020-03-17
Owner
  • Boehringer Ingelheim RCV GmbH & Co KG (Austria)
  • Lonza Ltd. (Switzerland)
  • Validogen GmbH (Austria)
Inventor
  • Gasser, Brigitte
  • Mattanovich, Diethard
  • Buchetics, Markus

Abstract

The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.

IPC Classes  ?

  • C12N 15/81 - Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
  • C12P 21/00 - Preparation of peptides or proteins

26.

RECOMBINANT HOST CELL ENGINEERED TO OVEREXPRESS HELPER PROTEINS

      
Document Number 02948369
Status In Force
Filing Date 2015-04-16
Open to Public Date 2015-10-22
Grant Date 2023-09-26
Owner
  • LONZA LTD. (Switzerland)
  • BOEHRINGER INGELHEIM RCV GMBH & CO KG (Austria)
  • VALIDOGEN GMBH (Austria)
Inventor
  • Gasser, Brigitte
  • Mattanovich, Diethard
  • Buchetics, Markus

Abstract

The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.

IPC Classes  ?

  • C07K 14/39 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from fungi from yeasts
  • C12N 1/15 - Fungi Culture media therefor modified by introduction of foreign genetic material
  • C12N 1/19 - YeastsCulture media therefor modified by introduction of foreign genetic material
  • C12N 9/16 - Hydrolases (3.) acting on ester bonds (3.1)
  • C12N 15/00 - Mutation or genetic engineeringDNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purificationUse of hosts therefor
  • C12N 15/31 - Genes encoding microbial proteins, e.g. enterotoxins
  • C12N 15/63 - Introduction of foreign genetic material using vectorsVectorsUse of hosts thereforRegulation of expression
  • C12N 15/67 - General methods for enhancing the expression
  • C12N 15/80 - Vectors or expression systems specially adapted for eukaryotic hosts for fungi
  • C12P 21/02 - Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

27.

RECOMBINANT HOST CELL FOR EXPRESSING PROTEINS OF INTEREST

      
Document Number 02945877
Status In Force
Filing Date 2015-04-16
Open to Public Date 2015-10-22
Grant Date 2023-09-05
Owner
  • LONZA LTD. (Switzerland)
  • BOEHRINGER INGELHEIM RCV GMBH & CO KG (Austria)
  • VALIDOGEN GMBH (Austria)
Inventor
  • Gasser, Brigitte
  • Mattanovich, Diethard
  • Buchetics, Markus

Abstract

The present invention is in the field of recombinant biotechnology, in particular in the field of protein expression. The invention generally relates to a method of expressing a protein of interest (POI) from a host cell. The invention relates particularly to improving a host cell's capacity to express and/or secrete a protein of interest and use of the host cell for protein expression. The invention also relates to cell culture technology, and more specifically to culturing cells to produce desired molecules for medical purposes or food products.

IPC Classes  ?

  • C07K 14/39 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from fungi from yeasts
  • C12N 1/19 - YeastsCulture media therefor modified by introduction of foreign genetic material
  • C12N 15/09 - Recombinant DNA-technology
  • C12N 15/31 - Genes encoding microbial proteins, e.g. enterotoxins
  • C12N 15/67 - General methods for enhancing the expression
  • C12N 15/81 - Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
  • C12P 21/02 - Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

28.

MUTANT AOX1 PROMOTERS

      
Document Number 02785161
Status In Force
Filing Date 2006-02-23
Open to Public Date 2006-08-31
Grant Date 2020-03-31
Owner
  • BOEHRINGER INGELHEIM RCV GMBH & CO KG (Austria)
  • VALIDOGEN GMBH (Austria)
Inventor
  • Hartner, Franz
  • Glieder, Anton

Abstract

A mutant Pichia pastoris alcohol oxidase 1 (AOXI) promoter of the wild type Pichia pastoris AOXI promoter (SEQ ID No. 1) comprising at least one mutation selected from the group consisting of : a) a transcription factor binding site (TFBS), b) nucleotides 170 to 235 (-784 to -719), nucleotides 170 to 191 (-784 to -763), nucleotides 192 to 213 (-762 to -741), nucleotides 192 to 210 (-762 to -744), nucleotides 207 to 209 (-747 to -745), nucleotides 214 to 235 (-740 to -719), nucleotides 304 to 350 (-650 to -604), nucleotides 364 to 393 (-590 to -561), nucleotides 434 to 508 (-520 to -446), nucleotides 509 to 551 (-445 to -403), nucleotides 552 to 560 (-402 to -394), nucleotides 585 to 617 (-369 to -337), nucleotides 621 to 660 (-333 to -294), nucleotides 625 to 683 (-329 to -271), nucleotides 736 to 741 (-218 to -213), nucleotides 737 to 738 (-217 to -216); nucleotides 726 to 755 (-228 to -199), nucleotides 784 to 800 (-170 to -154) or nucleotides 823 to 861 (-131 to -93) of Seq ID No. 1, and combinations thereof.

IPC Classes  ?

  • C12N 1/19 - YeastsCulture media therefor modified by introduction of foreign genetic material
  • C12N 9/04 - Oxidoreductases (1.), e.g. luciferase acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
  • C12N 15/113 - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
  • C12N 15/53 - Oxidoreductases (1)
  • C12N 15/79 - Vectors or expression systems specially adapted for eukaryotic hosts
  • C12N 15/81 - Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
  • C12P 21/02 - Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione